Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir-induced hyperbilirubinemia and vascular function in type 2 diabetes mellitus
2008-000771-17Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Type 2 diabetes mellitus with peripheral angiopathy comparing Atazanavir sequence with Placebo sequence (2 arms). Primary endpoint: Forearm vasodilatory response to vasoactive agents. Started Feb 2008; status: completed.
02
Drugs
atazanavir
03
Conditions
type 2 diabetes mellitus (T2DM)Type 2 diabetes mellitus with peripheral angiopathy
Beyond the preview
Go deeper on 2008-000771-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000771-17.